Gilead Provides Update on Phase 3 ASCENT-07 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/9/2026

1. AAPL
2. SPY
3. NUVL
4. RBRK
5. APLD
6. USO
7. GOOGL
8. SPCX
9. CPB
10. MTN

Go back to Gilead Provides Update on Phase 3 ASCENT-07 Study
Gilead Sciences (NASDAQ: GILD) Delayed: 125.50 -2.6 (2.03%)
Previous Close $128.10    52 Week High $108.63 
Open $128.80    52 Week Low $71.39 
Day High $129.00    P/E 69.34 
Day Low $123.20    EPS $1.81 
Volume 8,683,051